Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)
China · Delayed Price · Currency is CNY 25.41
+1.30 (5.39%)
Mar 27, 2026, 4:00 PM EDT
SHA:688163 Market Cap
SHA:688163 has a market cap or net worth of 2.92 billion as of March 30, 2026. Its market cap has increased by 51.23% in one year.
Market Cap
2.92B
Enterprise Value
2.13B
Revenue
196.21M
Ranking
n/a
PE Ratio
56.15
Stock Price
25.41
Market Cap Chart
Since March 11, 2022, SHA:688163's market cap has decreased from 5.98B to 2.92B, a decrease of -51.27%. That is a compound annual growth rate of -16.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 2.92B | 23.79% |
| Dec 31, 2025 | 2.36B | 23.97% |
| Dec 31, 2024 | 1.90B | -12.16% |
| Dec 29, 2023 | 2.16B | -5.22% |
| Dec 30, 2022 | 2.28B | -61.86% |
| Mar 11, 2022 | 5.98B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Model Organisms Center | 3.09B |
| Cabio Biotech (Wuhan) | 3.04B |
| Jiangsu Sihuan Bioengineering | 3.04B |
| Shanghai Hile Bio-Technology | 3.01B |
| Suzhou Fushilai Pharmaceutical | 2.85B |
| Novoprotein Scientific | 2.79B |
| Shandong Sito Bio-technology | 2.69B |
| Jilin Jian Yisheng Pharmaceutical | 2.67B |